Literature DB >> 26677227

Ras Regulates Rb via NORE1A.

Thibaut Barnoud1, Howard Donninger2, Geoffrey J Clark3.   

Abstract

Mutations in the Ras oncogene are one of the most frequent events in human cancer. Although Ras regulates numerous growth-promoting pathways to drive transformation, it can paradoxically promote an irreversible cell cycle arrest known as oncogene-induced senescence. Although senescence has clearly been implicated as a major defense mechanism against tumorigenesis, the mechanisms by which Ras can promote such a senescent phenotype remain poorly defined. We have shown recently that the Ras death effector NORE1A plays a critical role in promoting Ras-induced senescence and connects Ras to the regulation of the p53 tumor suppressor. We now show that NORE1A also connects Ras to the regulation of a second major prosenescent tumor suppressor, the retinoblastoma (Rb) protein. We show that Ras induces the formation of a complex between NORE1A and the phosphatase PP1A, promoting the activation of the Rb tumor suppressor by dephosphorylation. Furthermore, suppression of Rb reduces NORE1A senescence activity. These results, together with our previous findings, suggest that NORE1A acts as a critical tumor suppressor node, linking Ras to both the p53 and the Rb pathways to drive senescence.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  NORE1A; RASSF; Ras protein; cancer; cellular senescence; protein phosphorylation; retinoblastoma protein (pRb, RB)

Mesh:

Substances:

Year:  2015        PMID: 26677227      PMCID: PMC4742771          DOI: 10.1074/jbc.M115.697557

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

1.  The carboxyl-terminal region of the retinoblastoma protein binds non-competitively to protein phosphatase type 1alpha and inhibits catalytic activity.

Authors:  S Tamrakar; J W Ludlow
Journal:  J Biol Chem       Date:  2000-09-08       Impact factor: 5.157

Review 2.  RB and cell cycle progression.

Authors:  C Giacinti; A Giordano
Journal:  Oncogene       Date:  2006-08-28       Impact factor: 9.867

3.  The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit.

Authors:  T Durfee; K Becherer; P L Chen; S H Yeh; Y Yang; A E Kilburn; W H Lee; S J Elledge
Journal:  Genes Dev       Date:  1993-04       Impact factor: 11.361

4.  Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

Authors:  M Serrano; A W Lin; M E McCurrach; D Beach; S W Lowe
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

5.  Deletion of Rb accelerates pancreatic carcinogenesis by oncogenic Kras and impairs senescence in premalignant lesions.

Authors:  Catherine Carrière; A Jesse Gore; Alixanna M Norris; Jason R Gunn; Alison L Young; Daniel S Longnecker; Murray Korc
Journal:  Gastroenterology       Date:  2011-05-27       Impact factor: 22.682

6.  H-ras localizes to cell nuclei and varies with the cell cycle.

Authors:  Sara Contente; Tze-Jou Annie Yeh; Robert M Friedman
Journal:  Genes Cancer       Date:  2011-02

Review 7.  The RASSF1A tumor suppressor.

Authors:  Howard Donninger; Michele D Vos; Geoffrey J Clark
Journal:  J Cell Sci       Date:  2007-09-15       Impact factor: 5.285

Review 8.  Molecular mechanisms underlying RB protein function.

Authors:  Frederick A Dick; Seth M Rubin
Journal:  Nat Rev Mol Cell Biol       Date:  2013-04-18       Impact factor: 94.444

9.  The E3 ubiquitin ligase Itch regulates tumor suppressor protein RASSF5/NORE1 stability in an acetylation-dependent manner.

Authors:  R Suryaraja; M Anitha; K Anbarasu; G Kumari; S Mahalingam
Journal:  Cell Death Dis       Date:  2013-03-28       Impact factor: 8.469

Review 10.  The Ras-association domain family (RASSF) members and their role in human tumourigenesis.

Authors:  Louise van der Weyden; David J Adams
Journal:  Biochim Biophys Acta       Date:  2007-07-04
View more
  13 in total

1.  NORE1A is a double barreled Ras senescence effector that activates p53 and Rb.

Authors:  Howard Donninger; Thibaut Barnoud; Geoffrey J Clark
Journal:  Cell Cycle       Date:  2016-02-26       Impact factor: 4.534

Review 2.  Intrinsic protein disorder in oncogenic KRAS signaling.

Authors:  Ruth Nussinov; Hyunbum Jang; Chung-Jung Tsai; Tsung-Jen Liao; Shuai Li; David Fushman; Jian Zhang
Journal:  Cell Mol Life Sci       Date:  2017-06-08       Impact factor: 9.261

Review 3.  Tumor suppressor C-RASSF proteins.

Authors:  Hiroaki Iwasa; Shakhawoat Hossain; Yutaka Hata
Journal:  Cell Mol Life Sci       Date:  2018-01-20       Impact factor: 9.261

Review 4.  The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence.

Authors:  Thibaut Barnoud; M Lee Schmidt; Howard Donninger; Geoffrey J Clark
Journal:  Cancer Lett       Date:  2017-04-26       Impact factor: 8.679

Review 5.  Post-translational modifications on the retinoblastoma protein.

Authors:  Linbin Zhou; Danny Siu-Chun Ng; Jason C Yam; Li Jia Chen; Clement C Tham; Chi Pui Pang; Wai Kit Chu
Journal:  J Biomed Sci       Date:  2022-06-01       Impact factor: 12.771

Review 6.  Pumping the brakes on RAS - negative regulators and death effectors of RAS.

Authors:  Desmond R Harrell Stewart; Geoffrey J Clark
Journal:  J Cell Sci       Date:  2020-02-10       Impact factor: 5.285

Review 7.  Ras signaling through RASSF proteins.

Authors:  Howard Donninger; M Lee Schmidt; Jessica Mezzanotte; Thibaut Barnoud; Geoffrey J Clark
Journal:  Semin Cell Dev Biol       Date:  2016-06-08       Impact factor: 7.727

8.  The RASSF6 Tumor Suppressor Protein Regulates Apoptosis and Cell Cycle Progression via Retinoblastoma Protein.

Authors:  Shakhawoat Hossain; Hiroaki Iwasa; Aradhan Sarkar; Junichi Maruyama; Kyoko Arimoto-Matsuzaki; Yutaka Hata
Journal:  Mol Cell Biol       Date:  2018-08-15       Impact factor: 4.272

9.  Nonstructural protein 5B promotes degradation of the NORE1A tumor suppressor to facilitate hepatitis C virus replication.

Authors:  Payal Arora; Amartya Basu; M Lee Schmidt; Geoffrey J Clark; Howard Donninger; Daniel B Nichols; Diego F Calvisi; Neerja Kaushik-Basu
Journal:  Hepatology       Date:  2017-03-30       Impact factor: 17.425

10.  NORE1A Regulates MDM2 Via β-TrCP.

Authors:  M Lee Schmidt; Diego F Calvisi; Geoffrey J Clark
Journal:  Cancers (Basel)       Date:  2016-03-23       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.